Acute myeloid leukemia (AML) is a serious disease with complex etiology and marked variation in survival. Known prognostic factors include AML subtypes, age at diagnosis and sex. However, survival outcomes may vary across healthcare systems. This study evaluated the survival patterns in individuals diagnosed with AML at ages 0–24 years in the US and England between prognostic features and across countries.

SherllyXieaJobayer Hossain

Click here to read more